Drawing for FINDFTD

USPTO serial 90296467

FINDFTD

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SHANAHAN, PATRICK
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FINDFTD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa Greenwald-Swire

Lisa Greenwald-Swire FISH & RICHARDSON P.C.P.O. Box 1022Minneapolis, MN 55440-1022United States

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research services; DNA screening for scientific and medical research purposes; DNA screening for genetic mutations for scientific research purposes; genetic scientific research services in the field of dementia, neurodegenerative disorders, frontotemporal dementia, and Alzheimer's disease; DNA sequencing for medical and scientific research purposes; genetic medical research services in the field of dementia, neurodegenerative disorders, frontotemporal dementia, and Alzheimer's disease; providing medical and scientific research information in the field of dementia, neurodegenerative disorders, frontotemporal dementia, and Alzheimer's diseaseACTIVE—
044DNA screening for medical purposes; medical screening; medical testing services, namely, genetic testing services; DNA analysis and profiling for medical and diagnostic purposes; genetic and health information analysis and diagnostics for medical purposes; providing educational and medical information in the field of dementia, neurodegenerative disorders, frontotemporal dementia, and Alzheimer's disease; providing a website featuring information in the field of dementia, neurodegenerative disorders, frontotemporal dementia, and Alzheimer's diseaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 19, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 19, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 17, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 16, 2023EX5GSOU EXTENSION 5 GRANTED—
Nov 16, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 9, 2023EXT5SOU EXTENSION 5 FILED—
Nov 9, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 23, 2023EX4GSOU EXTENSION 4 GRANTED—
Jun 23, 2023EXT4SOU EXTENSION 4 FILED—
Jun 23, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 10, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 6, 2023EX3GSOU EXTENSION 3 GRANTED—
Jan 6, 2023EXT3SOU EXTENSION 3 FILED—
Jan 6, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 24, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 22, 2022EX2GSOU EXTENSION 2 GRANTED—
Jun 22, 2022EXT2SOU EXTENSION 2 FILED—
Jun 22, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 16, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 14, 2021EX1GSOU EXTENSION 1 GRANTED—
Dec 14, 2021EXT1SOU EXTENSION 1 FILED—
Dec 14, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 13, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 18, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 18, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 6, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 6, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 6, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 28, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 11, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 7, 2021DOCKASSIGNED TO EXAMINER—
Jan 3, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 6, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance